OBIO SEC Filings: 8-K, 10-Q, S-3 & 424B – Orchestra BioMed

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWOrchestra BioMed Announces Proposed Underwritten Public Offering of Common Stock

Nov 9, 2026

8-K

Orchestra BioMed Exceeds Full Enrollment Target in BACKBEAT Global Pivotal Trial of AVIM Therapy

Oct 1, 2026

8-K

Orchestra BioMed Corporate Overview and Pipeline Update

Sep 8, 2026

8-K

Orchestra BioMed Holdings, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 23, 2026

8-K

Orchestra BioMed Holdings, Inc. Approves 2026 Cash Bonus Plan and Compensation Adjustments

Feb 13, 2026

8-K

Orchestra BioMed to Receive Up to $21 Million from Vivasure Acquisition

Jan 12, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Nov 6, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Piper Sandler, TD Cowen, BTIG

Nov 5, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 8,027,890 | Warrants amount: 2,000,000

Nov 21, 2025

424B5

REGISTERED OFFERING

Aug 1, 2025

424B5

SHELF OFFERING | | Bank: Piper Sandler, TD Cowen

Jul 31, 2025

424B5

ATM | Offering amount: $100,000,000

Aug 12, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 23, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 6, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 6, 2026

S-3

SHARE RESALE REGISTRATION

Oct 31, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 19, 2025

S-3

SHELF | ATM | Offering amount: $300,000,000.00 EFFECTIVE

May 15, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jun 15, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2024

Ownerships

TYPE

HEADLINE

FILED AT

NEWFain Eric S (Reporting)

Nov 9, 2026

NEWPacitti David (Reporting)

Nov 9, 2026

NEWHochman David P (Reporting)

Nov 9, 2026

NEWTaylor Andrew Lawrence (Reporting)

Nov 9, 2026

Sherman Darren (Reporting)

Nov 3, 2026

144

Form 144 - Report of proposed sale of securities

Nov 2, 2026

Other

TYPE

HEADLINE

FILED AT

Orchestra BioMed Holdings, Inc. OBIO · SEC Filings